THERE IS NO EVIDENCE that anyone vaccinating against the Covid have a thrombotic risk major and there are no contraindications to vaccination (including AstraZeneca serum) in women taking estrogen-progestogen contraceptives or using hormone replacement therapy. To put it in black and white were the specialists of the Italian Society of Gynecology and Obstetrics (Sigo), the Italian Hospital Obstetricians Gynecologists Association (Aogoi) and the Italian University Gynecologists Association (Agui) who officially took a stand on anti-Covid vaccination19 and the (presumed) thrombotic risk in women with an interim position paper based on currently available scientific data.
No thrombotic risk
In the document, which was also shared by the Italian Menopause Society (Sim), the Italian Contraception Society (Sic) and the Italian Society of Gynecology of the Third Age (Sigite), the experts clarify that there is no data in the literature that highlights a increased thrombotic risk in the population subjected to the anti-Covid19 vaccine, and in particular AstraZeneca, compared to the general population. “Precisely for this reason – declares Elsa Viora, president of Aogoi -” in the Position paper we wanted to clarify that the anti-Covid19 vaccine cannot be considered a thrombotic risk factor to be added to any other anamnestic and personal risk factors that may be present “.
Covid vaccine and birth control pill
Specialists also commented on the alleged effects that the Covid vaccine could have on women who take the birth control pill. “There is no contraindication to vaccination in women who take estrogen-progestins such as hormonal contraception or hormone replacement therapy,” continues Viora.
No to genetic testing and aspirin after the vaccine
After the precautionary suspension of the Astrazeneca vaccine, among the various fake news circulated on the net and the unmotivated reactions of citizens, the idea of carrying out laboratory or instrumental tests to monitor a supposed thrombotic risk has also sprung up. Is it a well-founded precaution? “Absolutely not”, replies Viora. “In the Position paper we also reiterate that vaccination is not an indication to carry out genetic investigations to assess thrombophilic risk, nor to carry out preliminary investigations or implement antithrombotic prophylaxis after vaccination with low-dose aspirin or low molecular weight heparin”.
For women with thrombotic risk
How should women with increased thrombotic risk manage? “For those there is no evidence of absolute contraindications to vaccination”, replies the president Aogoi who adds: “Women at increased thrombotic risk during pregnancy must carry out a personalized antithrombotic prophylaxis in relation to the risk, but this condition is not a contraindication to ‘carrying out the anti-Covid-19 vaccination “.
.